Suppr超能文献

特定的蛋白水解切割限制了活细胞中可供MHC I类分子使用的肽库的多样性。

Specific proteolytic cleavages limit the diversity of the pool of peptides available to MHC class I molecules in living cells.

作者信息

Serwold T, Shastri N

机构信息

Division of Immunology, Department of Molecular and Cell Biology, University of California, Berkeley 94720, USA.

出版信息

J Immunol. 1999 Apr 15;162(8):4712-9.

Abstract

MHC class I molecules display peptides selected from a poorly characterized pool of peptides available in the endoplasmic reticulum. We analyzed the diversity of peptides available to MHC class I molecules by monitoring the generation of an OVA-derived octapeptide, OVA257-264 (SL8), and its C-terminally extended analog, SL8-I. The poorly antigenic SL8-I could be detected in cell extracts only after its conversion to the readily detectable SL8 with carboxypeptidase Y. Analysis of extracts from cells expressing the minimal precursor Met-SL8-I by this method revealed the presence of SL8/Kb and the extended SL8-I/Kb complexes, indicating that the peptide pool contained both peptides. In contrast, cells expressing full length OVA generated only the SL8/Kb complex, demonstrating that the peptide pool generated from the full length precursor contained only a subset of potential MHC-binding peptides. Deletion analysis revealed that SL8-I was generated only from precursors lacking additional C-terminal flanking residues, suggesting that the generation of the C terminus of the SL8 peptide involves a specific endopeptidase cleavage. To investigate the protease responsible for this cleavage, we tested the effect of different protease inhibitors on the generation of the SL8 and SL8-I peptides. Only the proteasome inhibitors blocked generation of SL8, but not SL8-I. These findings demonstrate that the specificities of the proteases in the Ag-processing pathway, which include but are not limited to the proteasome, limit the diversity of peptides available for binding by MHC class I molecules in the endoplasmic reticulum.

摘要

MHC I类分子展示从内质网中一组特征不明的肽库中选择的肽段。我们通过监测源自OVA的八肽OVA257 - 264(SL8)及其C末端延伸类似物SL8 - I的生成,分析了可用于MHC I类分子的肽段多样性。只有在用羧肽酶Y将抗原性较弱的SL8 - I转化为易于检测的SL8后,才能在细胞提取物中检测到它。用这种方法分析表达最小前体Met - SL8 - I的细胞提取物,发现存在SL8/Kb和延伸的SL8 - I/Kb复合物,表明肽库中包含这两种肽段。相比之下,表达全长OVA的细胞只产生SL8/Kb复合物,这表明从全长前体产生的肽库只包含潜在MHC结合肽的一个子集。缺失分析表明,SL8 - I仅从前体缺乏额外C末端侧翼残基的情况下产生,这表明SL8肽C末端的产生涉及特定的内肽酶切割。为了研究负责这种切割的蛋白酶,我们测试了不同蛋白酶抑制剂对SL8和SL8 - I肽段生成的影响。只有蛋白酶体抑制剂阻断了SL8的生成,而没有阻断SL8 - I的生成。这些发现表明,抗原加工途径中蛋白酶的特异性,包括但不限于蛋白酶体,限制了内质网中可用于MHC I类分子结合的肽段多样性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验